Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-x4r87 Total loading time: 0 Render date: 2024-04-28T09:12:32.880Z Has data issue: false hasContentIssue false

Chapter 13 - Service- and Setting-Related Challenges

Residential Care and Inpatient Settings

Published online by Cambridge University Press:  14 October 2021

By
Anne M. Doherty  and
Seán F. Dinneen
Edited by
Anne M. Doherty ,
Aoife M. Egan  and
Sean Dinneen
Anne M. Doherty
Affiliation:
University College Dublin
Aoife M. Egan
Affiliation:
Division of Endocrinology and Metabolism, Mayo Clinic, Minnesota, USA
Sean Dinneen
Affiliation:
School of Medicine, National University of Ireland, Galway
Get access

Summary

Given the high rates of diabetes being comorbid with many mental health conditions, it is no surprise that diabetes is very common in mental health facilities and settings. When the mortality gap in severe mental illness is considered, along with the fact that cardiovascular diseases (including diabetes as a cardiovascular risk factor) contribute greatly to this mortality gap, the importance of acting to reduce the impact of suboptimally managed diabetes in these settings is clear. Specific measures may be required to ensure that patients in these settings receive the usual standard of care. Factors such as acuity of illness, lack of insight into both mental and physical health problems and practical difficulties in attending appointments may mitigate against optimised diabetes management. This chapter considers specific challenges particular to various settings, and we will consider some measures that may help to ameliorate or fully overcome these barriers to optimised care. We will consider specific measures in various types of residential units and other settings (including inpatient settings), and we will explore different initiatives that have been used to overcome these challenges and close the mortality gap

Keywords

endocrinologydiabetesmental disorderspsychiatrymental health
Type
Chapter
Information
Mental Health, Diabetes and Endocrinology , pp. 137 - 146
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Roberts, E, Jones, L, Blackman, A, Dewhurst, T, Matcham, F, Kan, C, et al. The prevalence of diabetes mellitus and abnormal glucose metabolism in the inpatient psychiatric setting: a systematic review and meta-analysis. Gen Hosp Psychiatry. 2017; 45: 76–84.Google Scholar
JBDS, RCPsych. The Management of Diabetes in Adults and Children with Psychiatric Disorders in Inpatient Settings. Joint British Diabetes Societies and Royal College of Psychiatrists, 2017.Google Scholar
NICE. Type 2 Diabetes in Adults: Management [NG28]. National Institute for Health and Care Excellence, 2015.Google Scholar
NICE. Type 1 Diabetes in Adults: Diagnosis and Management [NG17]. National Institute for Health and Care Excellence, 2015.Google Scholar
Taylor, DM, Paton, C, Kapur, S. The Maudsley Prescribing Guidelines in Psychiatry. Wiley Blackwell, 2015.Google Scholar
ADA. Consensus development conference on antipsychotic drugs and obesity and diabetes. Obes Res. 2004; 12(2): 362–8.CrossRefGoogle Scholar
Cohen, D, Bogers, JP, van Dijk, D, Bakker, B, Schulte, PF. Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy. J Clin Psychiatry. 2012; 73(10): 1307–12.CrossRefGoogle ScholarPubMed
Morrato, EH, Newcomer, JW, Kamat, S, Baser, O, Harnett, J, Cuffel, B. Metabolic screening after the American Diabetes Association’s consensus statement on antipsychotic drugs and diabetes. Diabetes Care. 2009; 32(6): 1037–42.Google Scholar
Holt, RIG, Gossage-Worrall, R, Hind, D, Bradburn, MJ, McCrone, P, Morris, T, et al. Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE): randomised controlled trial. Br J Psychiatry. 2019; 214(2): 63–73.CrossRefGoogle ScholarPubMed
Lowndes, R. Diabetes Care and Serious Mental Illness: An Institutional Ethnography. Doctoral thesis. University of Toronto, 2012.Google Scholar
Hurley, L, O’Donnell, M, O’Caoimh, R, Dinneen, SF. Investigating the management of diabetes in nursing homes using a mixed methods approach. Diabetes Res Clin Pract. 2017; 127: 156–62.Google Scholar
Samara, MT, Dold, M, Gianatsi, M, Nikolakopoulou, A, Helfer, B, Salanti, G, et al. Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: a network meta-analysis. JAMA Psychiatry. 2016; 73(3): 199–210.Google Scholar
Henderson, DC, Cagliero, E, Gray, C, Nasrallah, RA, Hayden, DL, Schoenfeld, DA, et al. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study. Am J Psychiatry. 2000; 157(6): 975–81.Google Scholar
de Silva, VA, Suraweera, C, Ratnatunga, SS, Dayabandara, M, Wanniarachchi, N, Hanwella, R. Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis. BMC Psychiatry. 2016; 16(1): 341.Google Scholar
Ellinger, LK, Ipema, HJ, Stachnik, JM. Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain. Ann Pharmacother. 2010; 44(4): 668–79.CrossRefGoogle ScholarPubMed
Jiang, WL, Cai, DB, Yin, F, Zhang, L, Zhao, XW, He, J, et al. Adjunctive metformin for antipsychotic-induced dyslipidemia: a meta-analysis of randomized, double-blind, placebo-controlled trials. Transl Psychiatry. 2020; 10(1): 117.Google Scholar
Svensson, CK, Larsen, JR, Vedtofte, L, Jakobsen, MSL, Jespersen, HR, Jakobsen, MI, et al. One-year follow-up on liraglutide treatment for prediabetes and overweight/obesity in clozapine- or olanzapine-treated patients. Acta Psychiatr Scand. 2019; 139(1): 26–36.Google Scholar
Larsen, JR, Vedtofte, L, Jakobsen, MSL, Jespersen, HR, Jakobsen, MI, Svensson, CK, et al. Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia spectrum disorder: a randomized clinical trial. JAMA Psychiatry. 2017; 74(7): 719–28.CrossRefGoogle ScholarPubMed
Pozzi, M, Mazhar, F, Peeters, G, Vantaggiato, C, Nobile, M, Clementi, E, et al. A systematic review of the antidepressant effects of glucagon-like peptide 1 (GLP-1) functional agonists: Further link between metabolism and psychopathology: Special Section on ‘Translational and Neuroscience Studies in Affective Disorders’. Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders. J Affect Disord. 2019; 257: S0165-0327(19)30593–2.CrossRefGoogle ScholarPubMed
Gamble, JM, Chibrikov, E, Midodzi, WK, Twells, LK, Majumdar, SR. Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink. BMJ Open. 2018; 8(10): e023830.Google Scholar
Dixit, TS, Sharma, AN, Lucot, JB, Elased, KM. Antipsychotic-like effect of GLP-1 agonist liraglutide but not DPP-IV inhibitor sitagliptin in mouse model for psychosis. Physiol Behav. 2013; 114–115: 38–41.Google Scholar
Chowdhury, TA, Wright, R, Charlton, M. Insulin for the uninitiated. Clin Med (Lond). 2014; 14(6): 623–9.Google Scholar
Southern Health NHS Foundation Trust. Delegation of Medicines Administration to Non Registered Practitioners and Paid Carers by Registered Nurses in Integrated Community Services and Learning Disability. Southern Health NHS Foundation Trust, 2019.Google Scholar
Gillespie, H, Findlay White, F, Kennedy, N, Dornan, T. Enhancing Workplace Learning at the Transition into Practice. Lessons from a Pandemic. Medical Education, 2020.Google Scholar
Teasdale, SB, Samaras, K, Wade, T, Jarman, R, Ward, PB. A review of the nutritional challenges experienced by people living with severe mental illness: a role for dietitians in addressing physical health gaps. J Hum Nutr Diet. 2017; 30(5): 545–53.CrossRefGoogle ScholarPubMed
Hunt, K, Stiller, K. Dietetic and educational interventions improve clinical outcomes of diabetic and obese clients with mental impairment. Nutr Diet. 2017; 74(3): 236–42.Google Scholar
Curtis, J, Watkins, A, Rosenbaum, S, Teasdale, S, Kalucy, M, Samaras, K, et al. Evaluating an individualized lifestyle and life skills intervention to prevent antipsychotic-induced weight gain in first-episode psychosis. Early Interv Psychiatry. 2016; 10(3): 267–76.Google Scholar
Whittemore, R, Jaser, S, Chao, A, Jang, M, Grey, M. Psychological experience of parents of children with type 1 diabetes: a systematic mixed-studies review. Diabetes Educ. 2012; 38(4): 562–79.CrossRefGoogle ScholarPubMed
Polonsky, WH, Anderson, BJ, Lohrer, PA, Welch, G, Jacobson, AM, Aponte, JE, et al. Assessment of diabetes-related distress. Diabetes Care. 1995; 18(6): 754–60.CrossRefGoogle ScholarPubMed
Hagger, V, Hendrieckx, C, Sturt, J, Skinner, TC, Speight, J. Diabetes distress among adolescents with type 1 diabetes: a systematic review. Curr Diab Rep. 2016; 16(1): 9.Google Scholar
Huxley, RR, Peters, SA, Mishra, GD, Woodward, M. Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2015; 3(3): 198–206.Google Scholar
Eiser, C, Johnson, B, Brierley, S, Ayling, K, Young, V, Bottrell, K, et al. Using the Medical Research Council framework to develop a complex intervention to improve delivery of care for young people with type 1 diabetes. Diabet Med. 2013; 30(6): e223–8.Google Scholar
Jacobson, AM, Hauser, ST, Lavori, P, Willett, JB, Cole, CF, Wolfsdorf, JI, et al. Family environment and glycemic control: a four-year prospective study of children and adolescents with insulin-dependent diabetes mellitus. Psychosom Med. 1994; 56(5): 401–9.Google Scholar
Laffel, LM, Vangsness, L, Connell, A, Goebel-Fabbri, A, Butler, D, Anderson, BJ. Impact of ambulatory, family-focused teamwork intervention on glycemic control in youth with type 1 diabetes. J Pediatr. 2003; 142(4): 409–16.Google Scholar
Spaic, T, Robinson, T, Goldbloom, E, Gallego, P, Hramiak, I, Lawson, ML, et al. Closing the gap: results of the multicenter canadian randomized controlled trial of structured transition in young adults with type 1 diabetes. Diabetes Care. 2019; 42(6): 1018–26.CrossRefGoogle ScholarPubMed
Casey, B, Byrne, M, Casey, D, Gillespie, P, Hobbins, A, Newell, J, et al. Improving outcomes among young adults with type 1 diabetes: the D1 Now randomised pilot study protocol. Diabetic Med. 2020; 37(9): 1590–604.Google Scholar
Todd, PJ, Edwards, F, Spratling, L, Patel, NH, Amiel, SA, Sturt, J, et al. Evaluating the relationships of hypoglycaemia and HbA1c with screening‐detected diabetes distress in type 1 diabetes. Endocrinol Diabetes Metab. 2018; 1(1): e00003.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×